![](/img/cover-not-exists.png)
Clinical outcomes of IDH2 âmutated advancedâphase Phânegative myeloproliferative neoplasms treated with enasidenib
Patel, Anand A., Cahill, Kirk, CharnotâKatsikas, Angella, Liu, Hongtao, Gurbuxani, Sandeep, Thirman, Michael, Kosuri, Satyajit, Artz, Andrew S., Larson, Richard A., Stock, Wendy, Segal, Jeremy, OdenVolume:
190
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.16709
Date:
July, 2020
File:
PDF, 254 KB
2020